Judit Morla-Folch is a post-doctoral fellow at Nanomedicine Lab, where she works on the development and characterization of novel nanoimmunotherapeutics. Prior to joining Mount Sinai, she trained as a postdoctoral scholar at the Institut of Materials Sciences of Barcelona (ICMAB-CSIC) and New Jersey Institute of Technology (NJIT), working on the development of fluorescent nanoparticles for bioimaging and theragnostic. Her current research at Nanomedicine Lab is focused-on fighting cancer using photodynamic and targeted radiotherapies combined with immunotherapies.